A NOVEL NON MYELOABLATIVE REGIMEN FOR RELATED AND UNRELATED ALLOGENEIC TRANSPLANTATION OF HIGH RISK PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE (CGD)

被引：0
|
作者：
Kang, E. M. [1 ]
Kelly, C. [1 ]
Hilligoss, D. M. [1 ]
Marquesen, M. M. [1 ]
DeCastro, R. [1 ]
Wilder, J. [1 ]
Kwatemaa, A. N. [1 ]
Khuu, H. [1 ]
Stroncek, D. [1 ]
Malech, H. L. [1 ]
机构：
[1] NIH, Bethesda, MD 20892 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
390
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [1] Allogeneic Transplantation for High Risk Patients with Chronic Granulomatous Disease (CGD)
    Kang, Elizabeth
    BLOOD, 2022, 140 : 7570 - 7571
  • [2] Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for High Risk Chronic Granulomatous Disease (CGD) Patients
    Kang, Elizabeth M.
    Parta, Mark
    Hilligoss, Dianne
    Marquesen, Martha
    Kelly, Corin
    Kwatemaa, Akua
    Malech, Harry L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S327 - S328
  • [3] A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients
    Tsirigotis, Panagiotis
    Bitan, Reuven Or Menachem
    Resnick, Igor B.
    Samuel, Simcha
    Ackerstein, Aliza
    Elad, Sharon
    Gesundheit, Benjamin
    Zilberman, Irina
    Miron, Svetlana
    Leubovic, Alexander
    Slavin, Shimon
    Shapira, Michael Y.
    HAEMATOLOGICA, 2006, 91 (06) : 852 - 855
  • [4] Non-myeloablative conditioning regimen in patients with high risk acute myeloid leukemia:: unrelated and sibling allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Basara, N
    Roemer, E
    Günzelmann, S
    Schmetzer, B
    Fauser, AA
    Kiehl, MG
    BONE MARROW TRANSPLANTATION, 2001, 27 : S86 - S86
  • [5] Allogeneic Hemotopoietic Stem Cell Transplantation (HSCT) for Chronic Granulomatous Disease (CGD) in Childhood
    Paissiou, Anna
    Ioannidou, Elda
    Tzanoudaki, Marianna
    Oikonomopoulou, Christina
    Kaisari, Katerina
    Komitopoulou, Anna
    Spanou, Kleopatra
    Peristeri, Ioulia
    Konstantinidou, Niki
    Gousetis, Eugenios
    Vessalas, George
    Kitra, Vassiliki
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 452 - 453
  • [6] A fludarabine-based non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in chronic myeloid leukemia.
    Luo, Yi
    Huang, He
    Cai, Zhen
    Tan, Yamin
    Han, Xiaoyan
    BLOOD, 2006, 108 (11) : 436B - 436B
  • [7] Novel mutations in unrelated Vietnamese patients with chronic granulomatous disease
    Binh, Nguyen Thanh
    Lien, Nguyen Thi Kim
    Anh, Nguyen Thi Van
    Mai, Nguyen Thi Phuong
    Ha, Nguyen Thi Viet
    Ha, Dang Thuy
    Van Tung, Nguyen
    Hoang, Nguyen Huy
    CLINICA CHIMICA ACTA, 2022, 533 : 114 - 121
  • [8] Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease
    A Nagler
    A Ackerstein
    J Kapelushnik
    R Or
    E Naparstek
    S Slavin
    Bone Marrow Transplantation, 1999, 24 : 339 - 342
  • [9] Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease
    Nagler, A
    Ackerstein, A
    Kapelushnik, J
    Or, R
    Naparstek, E
    Slavin, S
    BONE MARROW TRANSPLANTATION, 1999, 24 (03) : 339 - 342
  • [10] Non-myeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
    Gerull, S
    Probst, S
    Ho, AD
    Goldschmidt, H
    Goerner, M
    Schaefer, H
    BLOOD, 2003, 102 (11) : 475B - 475B
12345